Novartis’s Sandimmun Faces Post-Recall Stockout, Re-Supply Expected after Late October

Novartis Pharma’s immunosuppressant Sandimmun Oral Solution 10% (ciclosporin) will face a temporary stockout following a voluntary recall, the company said on September 14. Supplies are scheduled to resume after late October. Earlier, crystal-like substances, which are not usually detected in...read more